Cargando…
Neuromodulation Treatments of Pathological Anxiety in Anxiety Disorders, Stressor-Related Disorders, and Major Depressive Disorder: A Dimensional Systematic Review and Meta-Analysis
BACKGROUND: Pathological anxiety is responsible for major functional impairments and resistance to conventional treatments in anxiety disorders (ADs), posttraumatic stress disorder (PTSD) and major depressive disorder (MDD). Focal neuromodulation therapies such as transcranial magnetic stimulation (...
Autores principales: | Gay, Florian, Singier, Allison, Aouizerate, Bruno, Salvo, Francesco, Bienvenu, Thomas C. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283719/ https://www.ncbi.nlm.nih.gov/pubmed/35845453 http://dx.doi.org/10.3389/fpsyt.2022.910897 |
Ejemplares similares
-
Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder
por: Muscatello, Maria Rosaria Anna, et al.
Publicado: (2019) -
Mapping the Presence of Anxiety Symptoms in Adults With Major Depressive Disorder
por: Ge, Fenfen, et al.
Publicado: (2021) -
Theta oscillations: A rhythm difference comparison between major depressive disorder and anxiety disorder
por: Zhang, Yu, et al.
Publicado: (2022) -
Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder
por: Dong, Zaiquan, et al.
Publicado: (2021) -
The role of leptin in indirectly mediating “somatic anxiety” symptoms in major depressive disorder
por: Zhu, Yue, et al.
Publicado: (2022)